A Multicenter, Open-label, Phase 1b Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Subjects
Clinical trial NCT01980589 · COMPLETED
Trial details
- NCT number
- NCT01980589
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2016-03-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.